U.S. flag

An official website of the United States government

NM_001283.5(AP1S1):c.186T>G (p.Tyr62Ter) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Apr 12, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000760751.6

Allele description [Variation Report for NM_001283.5(AP1S1):c.186T>G (p.Tyr62Ter)]

NM_001283.5(AP1S1):c.186T>G (p.Tyr62Ter)

Genes:
LOC126860125:BRD4-independent group 4 enhancer GRCh37_chr7:100799642-100800841 [Gene]
AP1S1:adaptor related protein complex 1 subunit sigma 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q22.1
Genomic location:
Preferred name:
NM_001283.5(AP1S1):c.186T>G (p.Tyr62Ter)
HGVS:
  • NC_000007.14:g.101157380T>G
  • NG_033082.2:g.7983T>G
  • NM_001283.5:c.186T>GMANE SELECT
  • NP_001274.1:p.Tyr62Ter
  • LRG_1363t1:c.186T>G
  • LRG_1363:g.7983T>G
  • LRG_1363p1:p.Tyr62Ter
  • NC_000007.13:g.100800661T>G
  • NM_001283.3:c.186T>G
Protein change:
Y62*
Links:
dbSNP: rs981747624
NCBI 1000 Genomes Browser:
rs981747624
Molecular consequence:
  • NM_001283.5:c.186T>G - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000890645GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Apr 12, 2022)
germlineclinical testing

Citation Link,

SCV003290664Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 2, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy.

Martinelli D, Travaglini L, Drouin CA, Ceballos-Picot I, Rizza T, Bertini E, Carrozzo R, Petrini S, de Lonlay P, El Hachem M, Hubert L, Montpetit A, Torre G, Dionisi-Vici C.

Brain. 2013 Mar;136(Pt 3):872-81. doi: 10.1093/brain/awt012. Epub 2013 Feb 18. Erratum in: Brain. 2013 Oct;136(Pt 10):e256.

PubMed [citation]
PMID:
23423674

Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.

Yamauchi M, Satta T, Ito A, Kondo K, Akiyama S, Ito K, Watanabe T, Takagi H.

J Surg Oncol. 1991 Jun;47(2):98-101.

PubMed [citation]
PMID:
1905767
See all PubMed Citations (3)

Details of each submission

From GeneDx, SCV000890645.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Has not been previously published as pathogenic or benign to our knowledge; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV003290664.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 620377). This variant has not been reported in the literature in individuals affected with AP1S1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr62*) in the AP1S1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP1S1 are known to be pathogenic (PMID: 23423674, 1905767).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 14, 2024